English

Convey Health Solutions Holdings, Inc.

EDGAR

CNVY Quarterly report (10-Q) · filed 2022-08-12

8 filing records in this dataset, filed from 2021-05-21 to 2022-08-12. Reported financial figures are available; chart coverage varies by period.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

89.8 million USD

2022 Q2 · USD

Exact inputs and evidence

Revenue: 89782000 USD Source

Operating margin

-9.34%

2022 Q2 · %

Exact inputs and evidence

Operating Income: -8385000 USD Source
Revenue: 89782000 USD Source

Operating cash flow

1.89 million USD

2022 Q2 · USD

Exact inputs and evidence

Operating Cash Flow: -13772000 USD Source
Operating Cash Flow: -15660000 USD Source

Free cash flow

415 thousand USD

2022 Q2 · USD

Exact inputs and evidence

Operating Cash Flow: -13772000 USD Source
Operating Cash Flow: -15660000 USD Source
Capital Expenditure: 3309000 USD Source
Capital Expenditure: 1836000 USD Source

Cash and cash equivalents: 19.7 million USD 2022-06-30 Source
Exact value

19714000 USD
Long-term debt including current maturities: 265 million USD 2022-06-30 Source
Exact value

265372000 USD
Shares outstanding: 73.2 million shares 2022-06-30 Source
Exact value

73221622 shares

Reported share-count change

0.29% · 208 thousand shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence

73013291 shares · 2021-06-30· Source
73221622 shares · 2022-06-30· Source

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

366 million USD

2021-07-01 – 2022-06-30

Exact inputs and evidence

Revenue: 82411000 USD · 2021-07-01 – 2021-09-30 Source
Revenue: 337596000 USD · 2021-01-01 – 2021-12-31 Source
Revenue: 240290000 USD · 2021-01-01 – 2021-09-30 Source
Revenue: 96708000 USD · 2022-01-01 – 2022-03-31 Source
Revenue: 89782000 USD · 2022-04-01 – 2022-06-30 Source

Net income

-6.95 million USD

2021-07-01 – 2022-06-30

Exact inputs and evidence

Net income: 3686000 USD · 2021-07-01 – 2021-09-30 Source
Net income: -9978000 USD · 2021-01-01 – 2021-12-31 Source
Net income: -10391000 USD · 2021-01-01 – 2021-09-30 Source
Net income: -1154000 USD · 2022-01-01 – 2022-03-31 Source
Net income: -9890000 USD · 2022-04-01 – 2022-06-30 Source

Operating cash flow

4.99 million USD

2021-07-01 – 2022-06-30

Exact inputs and evidence

Operating cash flow: -4823000 USD · 2021-01-01 – 2021-09-30 Source
Operating cash flow: -21073000 USD · 2021-01-01 – 2021-06-30 Source
Operating cash flow: -2315000 USD · 2021-01-01 – 2021-12-31 Source
Operating cash flow: -4823000 USD · 2021-01-01 – 2021-09-30 Source
Operating cash flow: -15660000 USD · 2022-01-01 – 2022-03-31 Source
Operating cash flow: -13772000 USD · 2022-01-01 – 2022-06-30 Source
Operating cash flow: -15660000 USD · 2022-01-01 – 2022-03-31 Source

Capital expenditure

5.88 million USD

2021-07-01 – 2022-06-30

Exact inputs and evidence

Capital expenditure: 4713000 USD · 2021-01-01 – 2021-09-30 Source
Capital expenditure: 3861000 USD · 2021-01-01 – 2021-06-30 Source
Capital expenditure: 6435000 USD · 2021-01-01 – 2021-12-31 Source
Capital expenditure: 4713000 USD · 2021-01-01 – 2021-09-30 Source
Capital expenditure: 1836000 USD · 2022-01-01 – 2022-03-31 Source
Capital expenditure: 3309000 USD · 2022-01-01 – 2022-06-30 Source
Capital expenditure: 1836000 USD · 2022-01-01 – 2022-03-31 Source

Free cash flow

-897 thousand USD

2021-07-01 – 2022-06-30

Exact inputs and evidence

Operating cash flow: -4823000 USD · 2021-01-01 – 2021-09-30 Source
Operating cash flow: -21073000 USD · 2021-01-01 – 2021-06-30 Source
Operating cash flow: -2315000 USD · 2021-01-01 – 2021-12-31 Source
Operating cash flow: -4823000 USD · 2021-01-01 – 2021-09-30 Source
Operating cash flow: -15660000 USD · 2022-01-01 – 2022-03-31 Source
Operating cash flow: -13772000 USD · 2022-01-01 – 2022-06-30 Source
Operating cash flow: -15660000 USD · 2022-01-01 – 2022-03-31 Source
Capital expenditure: 4713000 USD · 2021-01-01 – 2021-09-30 Source
Capital expenditure: 3861000 USD · 2021-01-01 – 2021-06-30 Source
Capital expenditure: 6435000 USD · 2021-01-01 – 2021-12-31 Source
Capital expenditure: 4713000 USD · 2021-01-01 – 2021-09-30 Source
Capital expenditure: 1836000 USD · 2022-01-01 – 2022-03-31 Source
Capital expenditure: 3309000 USD · 2022-01-01 – 2022-06-30 Source
Capital expenditure: 1836000 USD · 2022-01-01 – 2022-03-31 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2022-08-12.

Financial data available through: 2021-12-31.

Coverage by financial measure

Revenue: 2 of 11 periods available· newest 2021-12-31
Operating income: 2 of 11 periods available· newest 2021-12-31
Net income: 2 of 11 periods available· newest 2021-12-31
Operating cash flow: 2 of 11 periods available· newest 2021-12-31
Capital expenditure: 2 of 11 periods available· newest 2021-12-31
Total assets: 2 of 11 periods available· newest 2021-12-31
Total liabilities: 2 of 11 periods available· newest 2021-12-31
Current assets: 2 of 11 periods available· newest 2021-12-31
Current liabilities: 2 of 11 periods available· newest 2021-12-31
Cash and cash equivalents: 2 of 11 periods available· newest 2021-12-31
Long-term debt including current maturities: 2 of 11 periods available· newest 2021-12-31
Shares outstanding: 2 of 11 periods available· newest 2021-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
+19.3%

Prior period

USD 282.91 million

2020-01-01 – 2020-12-31
Current period

USD 337.6 million

2021-01-01 – 2021-12-31

Exact inputs and evidence

337596000 − 282914000 = 54682000 USD

282914000 USD · 2020-01-01 – 2020-12-31
Inspect prior input Prior source
337596000 USD · 2021-01-01 – 2021-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · Convey Health Solutions Holdings, Inc. · 2021-12-31 Convey Health Solutions Holdings, Inc. (edgar:1787640) Year-over-year change in Revenue: 54682000 USD Concept: fundies:Revenue Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-05T00:59:36Z Snapshot: 492d4a7d5b035c03e0872ef8a574c2f0be8b2f238b651aa785aa782608291024 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1787640?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 337596000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1787640/000162828022007046/cnvy-20211231.htm#2173920 Filing: 000162828022007046 Input fundies:Revenue: 282914000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1787640/000162828022007046/cnvy-20211231.htm#2196553 Filing: 000162828022007046
The citation records this snapshot. The page link may show a newer release later.
Net income
−USD 3.52 million

Prior period

−USD 6.46 million

2020-01-01 – 2020-12-31
Current period

−USD 9.98 million

2021-01-01 – 2021-12-31

Exact inputs and evidence

-9978000 − -6462000 = -3516000 USD

-6462000 USD · 2020-01-01 – 2020-12-31
Inspect prior input Prior source
-9978000 USD · 2021-01-01 – 2021-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · Convey Health Solutions Holdings, Inc. · 2021-12-31 Convey Health Solutions Holdings, Inc. (edgar:1787640) Year-over-year change in Net income: -3516000 USD Concept: fundies:NetIncome Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-05T00:59:36Z Snapshot: 492d4a7d5b035c03e0872ef8a574c2f0be8b2f238b651aa785aa782608291024 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1787640?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -9978000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1787640/000162828022007046/cnvy-20211231.htm#2036597 Filing: 000162828022007046 Input fundies:NetIncome: -6462000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1787640/000162828022007046/cnvy-20211231.htm#2037850 Filing: 000162828022007046
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
-107.3%

Prior period

USD 31.56 million

2020-01-01 – 2020-12-31
Current period

−USD 2.32 million

2021-01-01 – 2021-12-31

Exact inputs and evidence

-2315000 − 31563000 = -33878000 USD

31563000 USD · 2020-01-01 – 2020-12-31
Inspect prior input Prior source
-2315000 USD · 2021-01-01 – 2021-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · Convey Health Solutions Holdings, Inc. · 2021-12-31 Convey Health Solutions Holdings, Inc. (edgar:1787640) Year-over-year change in Operating cash flow: -33878000 USD Concept: fundies:OperatingCashFlow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-05T00:59:36Z Snapshot: 492d4a7d5b035c03e0872ef8a574c2f0be8b2f238b651aa785aa782608291024 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1787640?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -2315000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1787640/000162828022007046/cnvy-20211231.htm#1725704 Filing: 000162828022007046 Input fundies:OperatingCashFlow: 31563000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1787640/000162828022007046/cnvy-20211231.htm#1726753 Filing: 000162828022007046
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
+24.7%

Prior period

USD 5.16 million

2020-01-01 – 2020-12-31
Current period

USD 6.44 million

2021-01-01 – 2021-12-31

Exact inputs and evidence

6435000 − 5159000 = 1276000 USD

5159000 USD · 2020-01-01 – 2020-12-31
Inspect prior input Prior source
6435000 USD · 2021-01-01 – 2021-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · Convey Health Solutions Holdings, Inc. · 2021-12-31 Convey Health Solutions Holdings, Inc. (edgar:1787640) Year-over-year change in Capital expenditure: 1276000 USD Concept: fundies:CapitalExpenditure Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-05T00:59:36Z Snapshot: 492d4a7d5b035c03e0872ef8a574c2f0be8b2f238b651aa785aa782608291024 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1787640?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 6435000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1787640/000162828022007046/cnvy-20211231.htm#1735470 Filing: 000162828022007046 Input fundies:CapitalExpenditure: 5159000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1787640/000162828022007046/cnvy-20211231.htm#1736459 Filing: 000162828022007046
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2021 2021-01-01 – 2021-12-31

Revenue USD 337.6 million 100% of revenue
Operating costs Derived USD 325.88 million 97% of revenue
Operating income USD 11.71 million 3.5% of revenue
Tax, interest and other Derived USD 21.69 million 6.4% of revenue
Net income −USD 9.98 million −3% of revenue

Cash

Operating cash flow −USD 2.32 million −0.7% of revenue
Capital expenditure USD 6.44 million 1.9% of revenue
Free cash flow Derived −USD 8.75 million −2.6% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2020 Net loss: net income was −2.3% of revenue.
2021 Net loss: net income was −3% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2020 2020-01-01 – 2020-12-31	282914000	272463000 Derived	10451000	16913000 Derived	-6462000	26404000 Derived	Source 2020-01-01 – 2020-12-31: 282914000 USD Inspect Revenue Open source 2020-01-01 – 2020-12-31: 10451000 USD Inspect Operating Income Open source 2020-01-01 – 2020-12-31: -6462000 USD Inspect Net Income Open source 2020-01-01 – 2020-12-31: 31563000 USD Inspect Operating Cash Flow Open source 2020-01-01 – 2020-12-31: 5159000 USD Inspect Capital Expenditure Open source
2021 2021-01-01 – 2021-12-31	337596000	325884000 Derived	11712000	21690000 Derived	-9978000	-8750000 Derived	Source 2021-01-01 – 2021-12-31: 337596000 USD Inspect Revenue Open source 2021-01-01 – 2021-12-31: 11712000 USD Inspect Operating Income Open source 2021-01-01 – 2021-12-31: -9978000 USD Inspect Net Income Open source 2021-01-01 – 2021-12-31: -2315000 USD Inspect Operating Cash Flow Open source 2021-01-01 – 2021-12-31: 6435000 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 337.6M 2021

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20202020-12-31	Revenue	282914000	Revenue: 282914000 Open source
20212021-12-31	Revenue	337596000	Revenue: 337596000 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

19.3% 2021

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20202020-12-31	Year over year	No prior comparable period	Revenue: 282914000 Open source
20212021-12-31	Year over year	19.3%	Revenue: 337596000 Open source Revenue: 282914000 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin 3.5% 2021

Net margin -3% 2021

Free cash flow margin -2.6% 2021

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20202020-12-31	Operating margin	3.7%	Operating Income: 10451000 Open source Revenue: 282914000 Open source
20212021-12-31	Operating margin	3.5%	Operating Income: 11712000 Open source Revenue: 337596000 Open source
20202020-12-31	Net margin	-2.3%	Net Income: -6462000 Open source Revenue: 282914000 Open source
20212021-12-31	Net margin	-3%	Net Income: -9978000 Open source Revenue: 337596000 Open source
20202020-12-31	Free cash flow margin	9.3%	Revenue: 282914000 Open source Operating Cash Flow: 31563000 Open source Capital Expenditure: 5159000 Open source
20212021-12-31	Free cash flow margin	-2.6%	Revenue: 337596000 Open source Operating Cash Flow: -2315000 Open source Capital Expenditure: 6435000 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -2.3M 2021

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20202020-12-31	Operating cash flow	31563000	Operating Cash Flow: 31563000 Open source
20212021-12-31	Operating cash flow	-2315000	Operating Cash Flow: -2315000 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -8.8M 2021

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20202020-12-31	Free cash flow	26404000	Operating Cash Flow: 31563000 Open source Capital Expenditure: 5159000 Open source
20212021-12-31	Free cash flow	-8750000	Operating Cash Flow: -2315000 Open source Capital Expenditure: 6435000 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

35.2% 2021

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
20202020-12-31	Liabilities / assets	44.2%	Total Liabilities: 372918000 Open source Total Assets: 843068000 Open source
20212021-12-31	Liabilities / assets	35.2%	Total Liabilities: 292154000 Open source Total Assets: 829903000 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

1.88× 2021

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
20202020-12-31	Current assets / current liabilities	1.29×	Current Assets: 125829000 Open source Current Liabilities: 97794000 Open source
20212021-12-31	Current assets / current liabilities	1.88×	Current Assets: 132253000 Open source Current Liabilities: 70396000 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2020 2020-01-01 – 2020-12-31	−USD 6.46 million Exact value Exact value: -6462000 USD 2020-01-01 – 2020-12-31: -6462000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Convey Health Solutions Holdings, Inc. · 2020-12-31 Convey Health Solutions Holdings, Inc. (edgar:1787640) Net Income: -6462000 USD Concept: fundies:NetIncome Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-05T00:59:36Z Snapshot: 492d4a7d5b035c03e0872ef8a574c2f0be8b2f238b651aa785aa782608291024 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1787640/explain?concept=fundies%3ANetIncome&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:NetIncome: -6462000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1787640/000162828022007046/cnvy-20211231.htm#2037850 Filing: 000162828022007046 The citation records this snapshot. The page link may show a newer release later.	USD 31.56 million Exact value Exact value: 31563000 USD 2020-01-01 – 2020-12-31: 31563000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Convey Health Solutions Holdings, Inc. · 2020-12-31 Convey Health Solutions Holdings, Inc. (edgar:1787640) Operating Cash Flow: 31563000 USD Concept: fundies:OperatingCashFlow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-05T00:59:36Z Snapshot: 492d4a7d5b035c03e0872ef8a574c2f0be8b2f238b651aa785aa782608291024 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1787640/explain?concept=fundies%3AOperatingCashFlow&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 31563000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1787640/000162828022007046/cnvy-20211231.htm#1726753 Filing: 000162828022007046 The citation records this snapshot. The page link may show a newer release later.	USD 5.16 million Exact value Exact value: 5159000 USD 2020-01-01 – 2020-12-31: 5159000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Convey Health Solutions Holdings, Inc. · 2020-12-31 Convey Health Solutions Holdings, Inc. (edgar:1787640) Capital Expenditure: 5159000 USD Concept: fundies:CapitalExpenditure Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-05T00:59:36Z Snapshot: 492d4a7d5b035c03e0872ef8a574c2f0be8b2f238b651aa785aa782608291024 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1787640/explain?concept=fundies%3ACapitalExpenditure&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 5159000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1787640/000162828022007046/cnvy-20211231.htm#1736459 Filing: 000162828022007046 The citation records this snapshot. The page link may show a newer release later.	USD 26.4 million Calculation and evidence 31563000 − 5159000 USD Exact free cash flow: 26404000 USD 2020-01-01 – 2020-12-31: 31563000 USD · Inspect Operating Cash Flow · Source 2020-01-01 – 2020-12-31: 5159000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Convey Health Solutions Holdings, Inc. · 2020-12-31 Convey Health Solutions Holdings, Inc. (edgar:1787640) Free cash flow: 26404000 USD Concept: free-cash-flow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-05T00:59:36Z Snapshot: 492d4a7d5b035c03e0872ef8a574c2f0be8b2f238b651aa785aa782608291024 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1787640?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 31563000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1787640/000162828022007046/cnvy-20211231.htm#1726753 Filing: 000162828022007046 Input fundies:CapitalExpenditure: 5159000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1787640/000162828022007046/cnvy-20211231.htm#1736459 Filing: 000162828022007046 The citation records this snapshot. The page link may show a newer release later.
2021 2021-01-01 – 2021-12-31	−USD 9.98 million Exact value Exact value: -9978000 USD 2021-01-01 – 2021-12-31: -9978000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Convey Health Solutions Holdings, Inc. · 2021-12-31 Convey Health Solutions Holdings, Inc. (edgar:1787640) Net Income: -9978000 USD Concept: fundies:NetIncome Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-05T00:59:36Z Snapshot: 492d4a7d5b035c03e0872ef8a574c2f0be8b2f238b651aa785aa782608291024 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1787640/explain?concept=fundies%3ANetIncome&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:NetIncome: -9978000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1787640/000162828022007046/cnvy-20211231.htm#2036597 Filing: 000162828022007046 The citation records this snapshot. The page link may show a newer release later.	−USD 2.32 million Exact value Exact value: -2315000 USD 2021-01-01 – 2021-12-31: -2315000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Convey Health Solutions Holdings, Inc. · 2021-12-31 Convey Health Solutions Holdings, Inc. (edgar:1787640) Operating Cash Flow: -2315000 USD Concept: fundies:OperatingCashFlow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-05T00:59:36Z Snapshot: 492d4a7d5b035c03e0872ef8a574c2f0be8b2f238b651aa785aa782608291024 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1787640/explain?concept=fundies%3AOperatingCashFlow&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -2315000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1787640/000162828022007046/cnvy-20211231.htm#1725704 Filing: 000162828022007046 The citation records this snapshot. The page link may show a newer release later.	USD 6.44 million Exact value Exact value: 6435000 USD 2021-01-01 – 2021-12-31: 6435000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Convey Health Solutions Holdings, Inc. · 2021-12-31 Convey Health Solutions Holdings, Inc. (edgar:1787640) Capital Expenditure: 6435000 USD Concept: fundies:CapitalExpenditure Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-05T00:59:36Z Snapshot: 492d4a7d5b035c03e0872ef8a574c2f0be8b2f238b651aa785aa782608291024 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1787640/explain?concept=fundies%3ACapitalExpenditure&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 6435000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1787640/000162828022007046/cnvy-20211231.htm#1735470 Filing: 000162828022007046 The citation records this snapshot. The page link may show a newer release later.	−USD 8.75 million Calculation and evidence -2315000 − 6435000 USD Exact free cash flow: -8750000 USD 2021-01-01 – 2021-12-31: -2315000 USD · Inspect Operating Cash Flow · Source 2021-01-01 – 2021-12-31: 6435000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Convey Health Solutions Holdings, Inc. · 2021-12-31 Convey Health Solutions Holdings, Inc. (edgar:1787640) Free cash flow: -8750000 USD Concept: free-cash-flow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-05T00:59:36Z Snapshot: 492d4a7d5b035c03e0872ef8a574c2f0be8b2f238b651aa785aa782608291024 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1787640?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -2315000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1787640/000162828022007046/cnvy-20211231.htm#1725704 Filing: 000162828022007046 Input fundies:CapitalExpenditure: 6435000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1787640/000162828022007046/cnvy-20211231.htm#1735470 Filing: 000162828022007046 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

8 filings · 1,446 latest values · 1,446 originally reported values

Dataset published 2026-11-05. Source filing dates and reporting periods are shown separately.

Identifiers: 0001787640, 1787640, CNVY, edgar:1787640

Also known as Cannes Holding Parent, Inc., Convey Health Solutions Holdings, Inc., Convey Holding Parent, Inc.

Convey Health Solutions Holdings, Inc.

Latest quarter

Revenue

Operating margin

Operating cash flow

Free cash flow

Reported share-count change

Trailing twelve months

Revenue

Net income

Operating cash flow

Capital expenditure

Free cash flow

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2021 2021-01-01 – 2021-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation